Our aim was to explore the relationship between the cardiac biomarkers cTnI, cardiac troponin T (cTnT) and serum N-Terminal pro-brain natriuretic peptide (NT-proBNP) and the development of AKI and the need for RRT in a larger patient cohort than previously undertaken. This evidence concerns the gene NPPB and acute kidney injury.